ArticleClinical parkinsonism & related disorders2025
Distinct sensorimotor cough features in a cohort of Progressive Supranuclear Palsy.
Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Progressive Supranuclear Palsy (PSP) and Parkinson's disease (PD) similarly affect many neural substrates; however, some brain regions may be more impacted by PSP vs PD, giving rise to distinct cough features that could facilitate earlier differential diagnosis and inform airway protection therapies to prevent fatal lung infections, since patients may not effectively sense and clear irritants from their airways. Methods: Thirteen individuals with PSP participated and were age- and sex-matched to persons with PD and healthy, unaffected adults. Using a cross-sectional study design this study aimed to 1) compare cough function in PSP using voluntary and induced reflex cough testing, and 2) compare cough airflow and sensation metrics to PD and healthy adult groups. Results: Voluntary cough function, particularly cough effectiveness during the expiratory phase, was most impaired in the PSP group (P = 0.047), while expiratory phase timing outcomes only differed between PSP and healthy controls (P = 0.03) during reflex cough. There were no significant differences between groups regarding cough sensation to a cough-inducing stimulus (capsaicin), yet there were more cough responders in PSP vs. PD group. Conclusions: Degeneration of distinct neural substrates in PSP versus PD may give rise to differentiating sensorimotor cough deficits. Future directions should focus on cough interventions that maintain respiratory health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.